The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase1 clinical trial of high doses of Seleno-L-methionine (SLM), in sequential combination with axitinib in previously treated and relapsed clear cell renal cell carcinoma (ccRCC) patients.
 
Yousef Zakharia
Consulting or Advisory Role - Amgen; Castle Biosciences; Eisai; Exelixis; Novartis; Roche/Genentech
Travel, Accommodations, Expenses - Newlink Genetics
 
Rohan Garje
No Relationships to Disclose
 
James A. Brown
No Relationships to Disclose
 
Kenneth Gerard Nepple
No Relationships to Disclose
 
Laila Dahmoush
No Relationships to Disclose
 
Katherine Gibson-Corley
No Relationships to Disclose
 
Douglas Spitz
No Relationships to Disclose
 
Mohammed M. Milhem
Consulting or Advisory Role - Bristol-Myers Squibb; Eisai; EMD Serono; Genentech/Roche; Novartis
 
Youcef M. Rustum
No Relationships to Disclose